| 注册
首页|期刊导航|上海中医药杂志|中药基于MAPK信号通路干预急性肺损伤研究进展

中药基于MAPK信号通路干预急性肺损伤研究进展

白毅璇 万佳宜 马永明 李兴芳 周立文 田大成 陈艺伟 徐锦辉

上海中医药杂志2026,Vol.60Issue(7):74-82,9.
上海中医药杂志2026,Vol.60Issue(7):74-82,9.DOI:10.16305/j.1007-1334.2026.z20251011007

中药基于MAPK信号通路干预急性肺损伤研究进展

Research progress on Chinese materia medica intervention in acute lung injury based on MAPK signaling pathway

白毅璇 1万佳宜 2马永明 2李兴芳 3周立文 3田大成 3陈艺伟 3徐锦辉3

作者信息

  • 1. 甘肃中医药大学(甘肃 兰州 730030)
  • 2. 甘肃省中心医院(甘肃 兰州 730070)
  • 3. 甘肃省中医院(甘肃 兰州 730050)
  • 折叠

摘要

Abstract

Acute lung injury(ALI)is a common clinical critical condition of the respiratory system,and there is still a lack of specific drugs at present.The mitogen-activated protein kinase(MAPK)signaling pathway plays an important role in the pathological processes of ALI,such as inflammatory response and oxidative stress.In recent years,studies on Chinese materia medica intervening in ALI by regulating the MAPK pathway have become increasingly abundant,demonstrating the therapeutic advantages of multi-component and multi-target regulation.This review summarizes the mechanism of the MAPK signaling pathway in ALI and recent advances in the use of Chinese materia medica monomers and compound prescriptions to ameliorate lung injury.It focuses on the modulation of the MAPK pathway and its crosstalk with nuclear factor-κB(NF-κB),Toll-like receptor 4(TLR4),and related pathways.The aim is to provide insights for optimizing traditional Chinese medicine therapeutic strategies and facilitating the development of novel drugs for ALI.

关键词

急性肺损伤/丝裂原活化蛋白激酶/作用机制/炎症反应/氧化应激/中药研究

Key words

acute lung injury/mitogen-activated protein kinase/mechanism of action/inflammatory response/oxidative stress/Chinese materia medica research

引用本文复制引用

白毅璇,万佳宜,马永明,李兴芳,周立文,田大成,陈艺伟,徐锦辉..中药基于MAPK信号通路干预急性肺损伤研究进展[J].上海中医药杂志,2026,60(7):74-82,9.

基金项目

甘肃省自然科学基金项目(21JR11RA209) (21JR11RA209)

甘肃省科技厅甘肃省重点研发计划项目(21YF1FA061) (21YF1FA061)

上海中医药杂志

1007-1334

访问量0
|
下载量0
段落导航相关论文